Mark R. Hurtt
No más puestos en curso
Perfil
Mark R.
Hurtt has been Chief Medical Officer of Alseres Pharmaceuticals, Inc. since October 2005.
Previously, he was Senior Director-Clinical Research of Neurogen Corporation, Director-Drug Development and Director-Clinical Research of Pfizer Global Research and Development and Assistant Professor of Neurology and Pathology at the University of Pittsburgh.
Dr. Hurtt received an MD degree from Jefferson Medical College
Antiguos cargos conocidos de Mark R. Hurtt.
| Empresas | Cargo | Fin |
|---|---|---|
| University of Pittsburgh | Corporate Officer/Principal | - |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Director Técnico/Científico/I+D | - |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Director Técnico/Científico/I+D | - |
| ALSERES PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - |
Formación de Mark R. Hurtt.
| Sidney Kimmel Medical College | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALSERES PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
- Bolsa de valores
- Insiders
- Mark R. Hurtt
